Evidence map›Paper›PMID 30604211›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2019

Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα.

Zhenzhen Ma, Ruohan Yu, Jinxia Zhao, Lin Sun, Leilei Jian, Changhong Li, Xiangyuan Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Impacts of Hypoxia on Osteoclast Formation and Activity: Systematic Review.International journal of molecular sciences · 2021
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Amino Acid Metabolism in Bone Metastatic Disease.Current osteoporosis reports · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Observational
  15. The Adenosine ACells · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zhenzhen MaDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China.
Ruohan YuDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China.
Jinxia ZhaoDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China.
Lin SunDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China.
Leilei JianDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China.
Changhong LiDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China. changhongli@bjmu.edu.cn.
Xiangyuan LiuDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, 100191, China. liu-xiangyuan@263.net.
Peking University Third Hospital · CNPeking University · CN

Funding

National Natural Science Foundation of China No. 81471599the National Young Scholars Foundation of China No. 81501387the Prairie Fire Program LYJH-92
6 · The paper itself

Abstract

backgroundOsteoclasts are responsible for the bone loss in rheumatoid arthritis (RA). Hypoxia has been suggested to play key roles in pathological bone loss. However, the current understanding of the effects of hypoxia on osteoclastogenesis is controversial. Effects of hypoxia on both the formation and function of osteoclasts requires examination. In the current study, we aimed to explore the effect of hypoxia on osteoclast differentiation and the underlying mechanisms.

methodsRAW264.7 cells and murine bone-marrow-derived monocytes were used to induce osteoclastogenesis in the presence of macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor kappa B ligand (RANKL). Hypoxic conditions were maintained in a hypoxic chamber at 5% CO

resultsTRAP staining and the bone resorption assay revealed that hypoxia-restrained osteoclast differentiation and bone resorption. Expression of osteoclast markers including cathepsin K, RANK, and TRAP decreased during osteoclast differentiation under hypoxic conditions (all P < 0.05). Hypoxia at 1% O

conclusionsThese results suggest that constant hypoxia at 1% O

Indexed as

Cell DifferentiationAnimalsApoptosisBone Marrow CellsBone ResorptionHypoxiaI-kappa B ProteinsMacrophage Colony-Stimulating FactorMAP Kinase Kinase 4MAP Kinase Signaling SystemMiceNFATC Transcription FactorsOsteoclastsPhosphorylationRANK LigandRAW 264.7 CellsAcp5 protein, mouseI-kappa B ProteinsMacrophage Colony-Stimulating FactorMAP Kinase Kinase 4Nfatc1 protein, mouseNFATC Transcription FactorsRANK LigandTartrate-Resistant Acid PhosphataseTnfsf11 protein, mouseHypoxiaJNK-mitogen-activated protein kinasesNFATC transcription factorsOsteoclastOsteoclastogenesis

Identifiers

PMID30604211
OpenAlexW2908457758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.